Evaluation of microRNA expression profiles in triple-negative (ER, PR and Her2/neu) breast cancer patients with and without germ-line BRCA mutations

被引：0
|
作者：
Erturk, E. [1 ]
Cecener, G. [2 ]
Egeli, U. [2 ]
Tunca, B. [2 ]
Tezcan, G. [2 ]
Gokgoz, S. [3 ]
Tolunay, S. [4 ]
Tasdelen, I. [3 ]
机构：
[1] Uludag Univ, Vocat Sch Hlth Serv, Bursa, Turkey
[2] Uludag Univ, Fac Med, Dept Med Biol, Bursa, Turkey
[3] Uludag Univ, Fac Med, Dept Gen Surg, Bursa, Turkey
[4] Uludag Univ, Fac Med, Dept Pathol, Bursa, Turkey
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50355-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [21] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [22] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Michelle W. Wong-Brown
    Cliff J. Meldrum
    Jane E. Carpenter
    Christine L. Clarke
    Steven A. Narod
    Anna Jakubowska
    Helena Rudnicka
    Jan Lubinski
    Rodney J. Scott
    Breast Cancer Research and Treatment, 2015, 150 : 71 - 80
  • [23] Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer
    Schmidt, G.
    Juhasz-Boess, I.
    Gerlingeh, C.
    Rody, A.
    Liedtke, C.
    Fehm, T.
    Wiinberger, P.
    Stickeler, E.
    Mueller, E.
    Stein, S.
    Bohle, R.
    Solomayeri, E. -F.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 100 - 100
  • [24] Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer
    Gilda Schmidt
    Christoph Gerlinger
    Ingolf Juhasz-Böss
    Elmar Stickeler
    Achim Rody
    Cornelia Liedtke
    Pauline Wimberger
    Theresa Link
    Eberhard Müller
    Tanja Fehm
    Manuela Abel
    Stefan Stein
    Rainer Bohle
    Jan Endrikat
    Erich-Franz Solomayer
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1369 - 1376
  • [25] Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer
    Schmidt, Gilda
    Gerlinger, Christoph
    Juhasz-Boess, Ingolf
    Stickeler, Elmar
    Rody, Achim
    Liedtke, Cornelia
    Wimberger, Pauline
    Link, Theresa
    Mueller, Eberhard
    Fehm, Tanja
    Abel, Manuela
    Stein, Stefan
    Bohle, Rainer
    Endrikat, Jan
    Solomayer, Erich-Franz
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (06) : 1369 - 1376
  • [26] High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history
    Csokay, B
    Udvarhelyi, N
    Sulyok, Z
    Besznyak, I
    Ramus, S
    Ponder, B
    Olah, E
    CANCER RESEARCH, 1999, 59 (05) : 995 - 998
  • [27] Outcome of Triple Negative Breast Cancer in Patients with or without Deleterious BRCA Mutations
    Arun, B. K.
    Gutierrez-Barrera, A. M.
    Akar, U.
    Litton, J. K.
    Albarracin, C.
    Gonzalez-Angulo, A. M.
    Hortobagyi, G. N.
    CANCER RESEARCH, 2010, 70
  • [28] EVALUATION OF HER2/NEU EXPRESSION IN BREAST CANCER BONE METASTASES
    Juan Illarramendi, Jose
    Cordoba, Alicia
    Fernandez Seara, Pilar
    Lopez Cousillas, Alfredo
    Amat, Irene
    Reparaz, Begona
    Ruiz De Azua, Geranie
    De Miguel, Concepcion
    Salgado, Esteban
    Vera, Ruth
    Munoa, Javier
    BREAST, 2011, 20 : S28 - S28
  • [29] A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2
    Liede, A
    Rehal, P
    Vesprini, D
    Jack, E
    Abrahamson, J
    Narod, SA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) : 1543 - 1544
  • [30] ER/PR and Her2/Neu Correlation between Immunohistochemisty and Gene Expression Profiling in Women with Invasive Breast Cancer
    Dydo, M.
    Shutter, J.
    MODERN PATHOLOGY, 2010, 23 : 44A - 44A
12345